Gynecology最新文献

筛选
英文 中文
Acetylsalicylic acid as the only pharmacological method for the prevention of preeclampsia: A retrospective study 乙酰水杨酸作为预防子痫前期的唯一药理方法:回顾性研究
Gynecology Pub Date : 2023-07-14 DOI: 10.26442/20795696.2023.2.202231
O. Kravtsova, P. Kuznetsov, L. Dzhokhadze, Y. Dobrokhotova, A. M. Zatevalov
{"title":"Acetylsalicylic acid as the only pharmacological method for the prevention of preeclampsia: A retrospective study","authors":"O. Kravtsova, P. Kuznetsov, L. Dzhokhadze, Y. Dobrokhotova, A. M. Zatevalov","doi":"10.26442/20795696.2023.2.202231","DOIUrl":"https://doi.org/10.26442/20795696.2023.2.202231","url":null,"abstract":"Background. Preeclampsia (PE) complicates 28% of pregnancies worldwide, negatively impacting the pregnant woman and the fetus. Therefore, its prevention remains relevant. It is believed that the cause of PE, especially early PE, is a placentation disorder. It warrants studying drugs that can improve placenta development. The leadership in this matter is maintained by acetylsalicylic acid, which, according to the ASPRE study, reduced the incidence of PE at 34 weeks of pregnancy by 82%. The use of low molecular weight heparins (LMWH), dipyridamole, and antioxidants for PE prevention remains controversial and continues to be studied by foreign and Russian scientists. \u0000Aim. To assess the efficacy of acetylsalicylic acid, LMWH, dipyridamole (Curantyl), and bovine blood derivates (Actovegin) in the Russian population of pregnant women at high risk for PE prevention. \u0000Materials and methods. The study included 244 patients. We reviewed the archived case records of 103 patients diagnosed with severe PE, who delivered in 2019 at the State Clinical Hospital №24, and 141 pregnant women from the Maternity clinic №3 at the Veresaev Moscow State Clinical Hospital, where the risk of PE was assessed as high, according to the results of extended combined screening of the first trimester of pregnancy. Eighty-nine pregnant women received acetylsalicylic acid at a dose of 75 mg and 54 at a dose of 150 mg. In addition, 22 patients received LMWH, 6 dipyridamole, and 3 Actovegin. The absolute risks, the risk ratio, and statistical significance when taking drugs in each risk group were calculated to assess the efficacy of acetylsalicylic acid and other drugs for PE prevention in the above risk groups. \u0000Results. The resulting weak inverse correlation (r=-0.31) between the PE severity at delivery and the dose of acetylsalicylic acid indicates that an increase in the acetylsalicylic acid dose was associated with a decrease in the PE severity. The effectiveness of combinations of various drugs for PE prevention was assessed by analyzing factor correspondences. Two-dimensional scaling of the most likely combinations showed that most patients received acetylsalicylic acid in the high-risk group with no PE. Additional use of LMWH, Curantyl, and Actovegin did not reduce the risk of PE. \u0000Conclusion. Acetylsalicylic acid is the only pharmaceutical method for preventing PE in high-risk groups. Higher doses of acetylsalicylic acid are associated with lower PE severity.","PeriodicalId":36505,"journal":{"name":"Gynecology","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74612868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experience of the combined use of iron and folic acid preparations for the correction of latent iron deficiency in the clinical practice of an obstetrician-gynecologist. Clinical case 联合使用铁和叶酸制剂纠正潜伏性缺铁在妇产科医生临床实践中的体会。临床病例
Gynecology Pub Date : 2023-07-14 DOI: 10.26442/20795696.2023.2.202223
T. Zefirova, R. R. Mukhametova, A. T. Khaertdinov, E. M. Garipova
{"title":"Experience of the combined use of iron and folic acid preparations for the correction of latent iron deficiency in the clinical practice of an obstetrician-gynecologist. Clinical case","authors":"T. Zefirova, R. R. Mukhametova, A. T. Khaertdinov, E. M. Garipova","doi":"10.26442/20795696.2023.2.202223","DOIUrl":"https://doi.org/10.26442/20795696.2023.2.202223","url":null,"abstract":"Iron deficiency anemia is widespread among the female population. Pregnant women are a particularly vulnerable group, because the existing iron reserves are inadequate, and during pregnancy the need for iron for the formation of the placenta and fetal growth increases sharply, as a result, there is an imbalance between the intake and consumption of this trace element. Anemia increases the risks of various complications of gestation and multiplies maternal mortality. Note an increase in the frequency of premature childbirth, the threat of termination of pregnancy, placental insufficiency, weakness of labor, fetal development delay, fetal hypoxia, low birth weight of the newborn, the volume of pathological blood loss during childbirth and in the early postpartum period. At the same time, the development of these pathological conditions can be prevented by following modern protocols of pre-pregnancy preparation and pregnancy management. Prevention of anemia includes the use of various iron preparations, as well as new combinations, in particular a combination of 80 mg of elemental iron and 350 mcg of folic acid. In the article, we describe clinical cases demonstrating a rational preventive approach that prevents the development of clinical anemia and promotes safe perinatal outcomes for mother and fetus.","PeriodicalId":36505,"journal":{"name":"Gynecology","volume":"162 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80263149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of fetal alcohol syndrome on the mental and physical development of a preschool child: a clinical case 胎儿酒精综合征对学龄前儿童身心发育的影响:一个临床病例
Gynecology Pub Date : 2023-07-14 DOI: 10.26442/20795696.2023.2.202083
A. Marianian, E. Molchanova, A. M. Molchanova
{"title":"The effect of fetal alcohol syndrome on the mental and physical development of a preschool child: a clinical case","authors":"A. Marianian, E. Molchanova, A. M. Molchanova","doi":"10.26442/20795696.2023.2.202083","DOIUrl":"https://doi.org/10.26442/20795696.2023.2.202083","url":null,"abstract":"The article describes a clinical case demonstrating the effect of fetal alcohol syndrome on a preschool child's development, demonstrating the challenging diagnosis of this disorder, often leading to irreversible congenital mental and physical defects. The challenging diagnosis is because doctors are unaware of the mother's alcohol consumption during pregnancy. Doctors may suspect that the child has Fetal alcohol syndrome, according to the presence of facial dysmorphism and the state of health of the mother (pronounced signs of alcohol dependence). The clinical manifestations of the adverse effects of alcohol on the development of the child described in the article indicate the need to organize early diagnosis and comprehensive habilitation.","PeriodicalId":36505,"journal":{"name":"Gynecology","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87058400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics and confounders of the new coronavirus infection in low-risk pregnant women: an analysis of three years of the pandemic: A cross sectional study 低风险孕妇新型冠状病毒感染的临床特征和混杂因素:对三年大流行的分析:一项横断面研究
Gynecology Pub Date : 2023-07-14 DOI: 10.26442/20795696.2023.2.202240
T. Belokrinitskaya, N. I. Frolova, K. A. Kargina, E. A. Shametova, M. I. Chuprova, K. Rodionova
{"title":"Clinical characteristics and confounders of the new coronavirus infection in low-risk pregnant women: an analysis of three years of the pandemic: A cross sectional study","authors":"T. Belokrinitskaya, N. I. Frolova, K. A. Kargina, E. A. Shametova, M. I. Chuprova, K. Rodionova","doi":"10.26442/20795696.2023.2.202240","DOIUrl":"https://doi.org/10.26442/20795696.2023.2.202240","url":null,"abstract":"Background. During the three years of the new coronavirus infection (NCI) pandemic, young women of low infectious risk made a certain contribution to the severe maternal morbidity and mortality from COVID-19. \u0000Aim. To establish risk factors for morbidity and give a clinical assessment of COVID-19 during epidemic outbreaks in 2020, 2021, and 2022 in low-risk pregnant women. \u0000Materials and methods. The study included three groups of pregnant women with clinically manifested and laboratory-confirmed SARS-CoV-2 infection: 163 pregnant women who became ill in the first wave of the epidemic in October-December 2020, 158 in the second and third epidemic wave in July and October 2021, and 160 in the fourth epidemic wave in JanuaryFebruary 2022. Each comparison group included 100 pregnant women who did not become ill during the same periods of the pandemic. Patients of all groups were in the III trimester of gestation, comparable in age (1835 years), social status, parity, and body mass index, and had no known risk factors for COVID-19. \u0000Results. Iron-deficiency anemia, tobacco smoking, and belonging to the East Asian ethnic group showed a stable association with the incidence of COVID-19 in low-risk pregnant women. In the first year of the pandemic (strains zero and Alpha), the clinical presentation of NCI was dominated by a loss of smell and/or taste (87.7%), drowsiness (68.7%), and dyspnea even with a mild degree of lung damage (68.1%). The epidemics of the second year of the COVID-19 pandemic (Delta strain) were characterized by a more severe course of the disease than in the first year: fever was more often reported above 38C (19.6% vs 7.4%; p2=0.006), pneumonia confirmed by computed tomography (61.4% vs 21.4%; p20.001), severe lung damage (CT-3: 11.4% vs 4.9%; p2=0.040; CT-4: 0 vs 6.3%; p20.05), intensive care unit admission (11.4% vs 6.4%; p2=0.041); there were cases of invasive mechanical ventilation (1.89% vs 0; p2=0.118) and deaths (0.63% vs 0; p2=0.492). In the epidemic of the third year of the pandemic (Omicron strain), the COVID-19 clinical presentation was similar to seasonal acute respiratory viral infection: the predominant symptoms included runny nose (66.7%) and cough (54.4%); pneumonia was rare (3.8%). \u0000Conclusion. Iron deficiency anemia, tobacco smoking, and belonging to the East Asian ethnic group are confounders of COVID-19 disease in pregnant women without known infectious risk factors. Unlike the epidemics of the first and third year of the pandemic with dominant zero, Alpha, and Omicron strains, epidemic outbreaks of the second year of COVID-19 caused by the Delta strain were characterized by the most severe disease course, a high rate of pneumonia and deaths even in low-risk patients.","PeriodicalId":36505,"journal":{"name":"Gynecology","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84579503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National medical eligibility criteria for contraceptive use 2023: focus on women's reproductive health: A review 2023年国家避孕药具使用医疗资格标准:重点关注妇女生殖健康:审查
Gynecology Pub Date : 2023-07-14 DOI: 10.26442/20795696.2023.2.202236
E. Andreeva, E. Sheremetyeva, V. Prilepskaya
{"title":"National medical eligibility criteria for contraceptive use 2023: focus on women's reproductive health: A review","authors":"E. Andreeva, E. Sheremetyeva, V. Prilepskaya","doi":"10.26442/20795696.2023.2.202236","DOIUrl":"https://doi.org/10.26442/20795696.2023.2.202236","url":null,"abstract":"Reproductive health care involves helping families in this area with the provision of the necessary information. This is recognized as a key step in improving the health of men, women and children and is a fundamental human right. Everyone has the right to have access to a correct understanding of reproductive health care, choice of contraceptive method and the opportunity to benefit from scientific progress in this area. Over the past 35 years, significant progress has been made in the development of new contraceptives: the content of hormones in combined oral contraceptives has significantly decreased, inert intrauterine contraceptives have been replaced by more progressive, levonorgestrel-containing ones including low-dose generation. Combined hormonal compounds were synthesized in the form of injections, patches and vaginal rings, progestogen implantable and injectable contraceptives. Women who use contraceptives must take into account the state of health (including the presence of endocrine pathology) in order to use them without harm to their health. Based on the World Health Organization Medical Eligibility Criteria for Contraceptive Methods 2015, the Russian Medical Eligibility Criteria for Contraceptive Methods 2023 is designed to become an important tool in daily practice of doctors.","PeriodicalId":36505,"journal":{"name":"Gynecology","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87229533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The polymorphic locus rs1799945 of the HFE gene determines the risk of severe preeclampsia HFE基因的多态性位点rs1799945决定了严重子痫前期的风险
Gynecology Pub Date : 2023-07-14 DOI: 10.26442/20795696.2023.2.202062
M. Abramova, I. Ponomarenko, V. Orlova, I. Batlutskaya, O. Efremova, M. Churnosov
{"title":"The polymorphic locus rs1799945 of the HFE gene determines the risk of severe preeclampsia","authors":"M. Abramova, I. Ponomarenko, V. Orlova, I. Batlutskaya, O. Efremova, M. Churnosov","doi":"10.26442/20795696.2023.2.202062","DOIUrl":"https://doi.org/10.26442/20795696.2023.2.202062","url":null,"abstract":"Background. Preeclampsia (PE) is a gestation complication that affects not only maternal and perinatal mortality but also the quality of life of women who have undergone PE, as well as their children in later life, which determines the urgency and relevance of the search for early markers of this complication of pregnancy, including genetic determinants. \u0000Aim. To evaluate the associations of GWAS-related hypertension candidate genes with the occurrence of severe PE. \u0000Materials and methods. All patients included in this study (217 females with severe PE and 498 females with physiological pregnancies) underwent a molecular genetic study of five GWAS-significant polymorphic loci of arterial hypertension candidate genes (rs1799945 HFE, rs805303 BAG6, rs4387287 OBFC1, rs633185 ARHGAP42, rs2681472 ATP2B1) and assessed the compliance of the empirical distribution of allelic variants and genotypes theoretically expected under HardyWeinberg law (at pbonf0.01). The associative search was performed using logistic regression analysis, and the odds ratio and its 95% confidence interval were calculated in PLINK v. 2.050. For polymorphisms that showed significant associations with severe PE, their regulatory effects were considered when using international projects on functional genomics (GTExportal, HaploReg (v4.1), PolyPhen-2). \u0000Results. The GG genotype of the rs1799945 polymorphic locus of the HFE gene is significantly associated with an increased risk of severe PE within the recessive genetic model (odds ratio 2.41; pperm=0.01). The polymorphism of rs1799945 of the HFE gene is localized in the histone markers H3K4me1 and H3K4me3 in pathogenetically significant organs and tissues for the development of PE, located in an evolutionarily conserved region located in the area of hypersensitivity to DNase-1. The rs1799945 locus of the HFE gene determines the missense mutation (aspartic acid replaces the amino acid histidine at position 63 in the Hereditary hemochromatosis protein) with the BENIGN predictor potential. \u0000Conclusion. The rs1799945 polymorphic locus of the HFE gene is associated with a high risk of severe PE.","PeriodicalId":36505,"journal":{"name":"Gynecology","volume":"114 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80129422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secnidazol`s effectiveness for the bacterial vaginosis treatment 塞克硝唑治疗细菌性阴道病的疗效观察
Gynecology Pub Date : 2023-07-14 DOI: 10.26442/20795696.2023.2.202257
O. Serova, Galina M. Shmeleva, Natalia V. Shutikova
{"title":"Secnidazol`s effectiveness for the bacterial vaginosis treatment","authors":"O. Serova, Galina M. Shmeleva, Natalia V. Shutikova","doi":"10.26442/20795696.2023.2.202257","DOIUrl":"https://doi.org/10.26442/20795696.2023.2.202257","url":null,"abstract":"Background. Bacterial vaginosis is an infectious non-inflammatory syndrome with polymicrobial etiology associated with dysbiosis of the vaginal biotope. \u0000Aim. To assess the clinical efficacy and safety of Secnidox in treating bacterial vaginosis in women 2059 years. \u0000Materials and methods. The study included 30 patients (mean age 31.14.7 years) with bacterial vaginosis who received 2 g of secnidazole (Secnidox) as a single dose. All patients were followed up by an obstetrician-gynecologist at two visits. \u0000Results. Secnidazole provided sanitation of the vagina. Normalization of clinical symptoms and laboratory tests was reported. \u0000Conclusion. Secnidazole showed good therapeutic efficacy and normalization of the vaginal microflora.","PeriodicalId":36505,"journal":{"name":"Gynecology","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85073790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuroprotective effects of estetrol in combined oral contraceptives: A review 联合口服避孕药中甾醇的神经保护作用综述
Gynecology Pub Date : 2023-07-14 DOI: 10.26442/20795696.2023.2.202052
M. R. Orazov, V. V. Ermakov, Dmitrii S. Novginov
{"title":"Neuroprotective effects of estetrol in combined oral contraceptives: A review","authors":"M. R. Orazov, V. V. Ermakov, Dmitrii S. Novginov","doi":"10.26442/20795696.2023.2.202052","DOIUrl":"https://doi.org/10.26442/20795696.2023.2.202052","url":null,"abstract":"One of the most effective contraception methods is combined hormonal contraceptives. According to the current prescribing information, in addition to their primary effect, they have several concomitant positive effects on the female body non-contraceptive effects. These include a well-predictable and controlled \"menstrual cycle\" (menstrual-like reaction), anti-androgenic effect, anti-anemic effect due to reduced menstrual blood loss, reducing the severity of dysmenorrhea and premenstrual syndrome, reducing the risk of pelvic inflammatory diseases, ectopic pregnancy, and some benign and malignant tumors of the reproductive system. Combined oral contraceptives (COCs) also have effects on the central nervous system, hypothalamic-pituitary structures that regulate sex hormones, and the psycho-emotional health of women. For a long time, the main estrogen component of COCs remained ethinylestradiol. Although not well-studied, its mechanisms of action on the nervous system are similar, regardless of the progestogen component. However, the effect was not entirely positive: taking contraceptives containing ethinylestradiol can lead to increased emotional lability, anxiety, and depressive disorders. It drives researchers to search for new estrogen without these adverse properties. Such is the long-known but overlooked esthetrol. Numerous studies indicate a pronounced neuroprotective effect of esthetrol, which can increase patients' satisfaction with hormonal contraceptives and their compliance. It also opens up great opportunities for the use of this drug beyond gynecological practice.","PeriodicalId":36505,"journal":{"name":"Gynecology","volume":"60 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82022879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complex questions about combined hormonal contraception: A review 联合激素避孕的复杂问题:综述
Gynecology Pub Date : 2023-07-14 DOI: 10.26442/20795696.2023.2.202245
V. Prilepskaya, Lana L. Bostandzhian
{"title":"Complex questions about combined hormonal contraception: A review","authors":"V. Prilepskaya, Lana L. Bostandzhian","doi":"10.26442/20795696.2023.2.202245","DOIUrl":"https://doi.org/10.26442/20795696.2023.2.202245","url":null,"abstract":"Combined oral contraceptives (COCs) containing synthetic analogs of sex steroids are considered the most effective and popular method of contraception worldwide. The low rate of hormonal contraceptive use is often because of the fear of side effects due to existing myths. Complex questions that most often arise among doctors and patients when choosing COCs include the risk of thrombosis and cancer, the effect on fertility after the use of COCs, the use of COCs in patients with COVID-19, etc. COCs are highly effective, well-studied, and pose minimal risks that are well understood, described in the labels, and can be avoided with proper use.","PeriodicalId":36505,"journal":{"name":"Gynecology","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88855567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative characteristics of reproductive function in mentally healthy and mentally ill women with infertility 精神健康和精神疾病不孕妇女生殖功能的比较特点
Gynecology Pub Date : 2023-07-14 DOI: 10.26442/20795696.2023.2.201838
N. Tyuvina, Angelina O. Nikolayevskaya, V. Balabanova, Kaleriia N. Ilchenko
{"title":"Comparative characteristics of reproductive function in mentally healthy and mentally ill women with infertility","authors":"N. Tyuvina, Angelina O. Nikolayevskaya, V. Balabanova, Kaleriia N. Ilchenko","doi":"10.26442/20795696.2023.2.201838","DOIUrl":"https://doi.org/10.26442/20795696.2023.2.201838","url":null,"abstract":"Background. Issues of the relationship and interaction of menstrual and reproductive function and the mental state of women are not sufficiently studied and need additional research. \u0000Aim. To conduct a comparative assessment of individual indicators of reproductive function in mentally healthy and mentally ill women with infertility. \u0000Materials and methods. Of the 348 women with primary and secondary infertility aged 21 to 40 included in the study, 120 had been treated for a psychiatric disorder in a psychiatric hospital before this study. Patients were clinically evaluated using a specially designed questionnaire card and subsequent statistical processing of the results obtained. \u0000Results. The menstrual-generative function of patients in the study groups significantly differed in several indicators. Mentally ill women with primary infertility were characterized by a later age of menarche, menstruation irregularity or absence during the disease exacerbation, scanty menstruations or heavy menstrual bleeding, inadequate emotional response to menarche, and irregularity and dissatisfaction with sexual life. Spontaneous miscarriages and stillbirths were more common in mentally ill women, especially those with endogenous diseases (schizophrenia, affective disorders), and abortions and gynecological operations were more common in mentally healthy women. Predictors of infertility related to mental health were early onset and chronic course of mental disorder, severity and duration of the disease exacerbations, short and incomplete remissions, and personality changes or a defect (schizophrenic) due to mental illness. \u0000Conclusion. Menstrual and reproductive functions of women depend on their mental state. In women with mental conditions, menstrual function disorders, along with psychopathological symptoms of diseases (a decrease in sexual vigor, communication, anesthesia of feelings), and decreased social and family adaptation, lead to reproductive function disorders. Improving a woman's mental state can contribute to the recovery of her reproductive function.","PeriodicalId":36505,"journal":{"name":"Gynecology","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88502702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信